PNOĒ Unveils Self‑Serve Breath Mask for Gym Users, Promises Lab‑Grade VO₂ Max Readings in Minutes

Malden, Massachusetts‑based health‑tech startup PNOĒ is preparing to roll out a new version of its breath‑analyzing face mask on October 1, targeting fitness centers and individual athletes who want quick, laboratory‑quality metabolic data without a technician.

The updated mask, described by the company as a “sleeker, self‑serve” device, can estimate a user’s VO₂ max and several other metabolic markers in roughly eight minutes. By analyzing the composition of exhaled air, the system translates breath chemistry into metrics traditionally derived from treadmill or cycle ergometer tests that require specialized equipment and trained staff.

PNOĒ’s original mask, which attracted attention for its dramatic, Bane‑inspired design, was primarily positioned as a research‑grade tool for clinical settings. The new model trims the aesthetic excess and adds an intuitive interface that guides users through a short breathing protocol before delivering results on a built‑in display or via a companion app.

Fitness professionals see the technology as a potential game‑changer for personal training and group classes. Accurate VO₂ max readings help gauge cardiovascular fitness, set appropriate training zones, and track progress over time. By condensing what once required a lab visit into a quick in‑gym check, the mask could streamline performance assessments and reduce reliance on external testing services.

Industry observers note that the move aligns with a broader trend toward consumer‑direct health monitoring, where devices such as wearable heart‑rate monitors and blood‑oxygen sensors have become commonplace. Breath analysis, however, remains relatively niche, and PNOĒ’s claim of “lab‑grade” accuracy will likely be scrutinized by both regulators and the scientific community.

Regulatory pathways for breath‑based diagnostics vary by jurisdiction, but the company has indicated that the mask is intended for wellness and fitness use rather than medical diagnosis. This positioning may simplify market entry while still offering data that athletes and coaches can incorporate into training plans.

Early adopters at select pilot gyms will test the mask ahead of the public launch, providing feedback on usability, data reliability, and integration with existing fitness platforms. The company plans to expand distribution through equipment vendors and possibly direct‑to‑consumer channels later in the year.

If the device delivers on its promise, it could democratize access to high‑resolution metabolic testing, allowing more people to tailor workouts based on precise physiological feedback. The rollout will also serve as a litmus test for how quickly the fitness industry embraces breath‑based analytics as a standard metric alongside heart rate and power output.